Scientists seek lung disease clues from blood and breath samples
NCT ID NCT01776398
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study collects blood, airway, and urine samples from 2,000 healthy volunteers and people with lung diseases like COPD and pulmonary fibrosis. Researchers will compare samples to establish normal ranges and learn how genes change in lung disease. The goal is to better understand what causes these conditions, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine
RECRUITINGNew York, New York, 10065-4870, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug combo break the smoking habit?
- Personalized nicotine patch dosing may boost quit rates
- New inhaled compound aims to ease COPD breathing woes
- Talking it out: could a Conversation-Based approach curb smoking in future nurses?
- Ultrasound might reveal hidden lung damage in COPD
- A stronger nicotine patch might break the dual Smoking-Vaping habit